Inventor · disambiguated record
Juliette Hordeaux
Also filed as: HORDEAUX JULIETTE
5 granted patents·18 pending applications·2 citations·filing 2018–2025
66Inventor score
Files withUNIV PENNSYLVANIA23
Top patents by PatentIndex Score
23 records- 0184US11555206B2Gene therapy for mucopolysaccharidosis IIIAUNIV PENNSYLVANIA·Filed 2018·Granted Jan 17, 2023·2 cites·25 claims
- 0280US12428653B2Gene therapy for ceroid lipofuscinosesUNIV PENNSYLVANIA·Filed 2022·Granted Sep 30, 2025·0 cites·47 claims
- 0371US2024009327A1Gene therapy for mucopolysaccharidosis iiibUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 0468US2023279430A1Gene therapy for mucopolysaccharidosis iiiaUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 0566US11723989B2Gene therapy for mucopolysaccharidosis IIIBUNIV PENNSYLVANIA·Filed 2018·Granted Aug 15, 2023·0 cites·28 claims
- 0665US12338451B2Compositions useful in treatment of metachromatic leukodystrophyUNIV PENNSYLVANIA·Filed 2020·Granted Jun 24, 2025·0 cites·28 claims
- 0765US2025313859A1Compositions useful in treatment of metachromatic leukodystrophyUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 0863US11591614B2Gene therapy for ceroid lipofuscinosesUNIV PENNSYLVANIA·Filed 2018·Granted Feb 28, 2023·0 cites·30 claims
- 0962US2025041445A1Gene therapy for treatment of mucopolysaccharidosis iiiaUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 1061US2025177495A1Compositions useful in treatment of metachromatic leukodystrophyUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 1159US2025295807A1Compositions for drg-specific reduction of transgene expressionUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 1259US2024408157A1Compositions and methods for treatment of fabry diseaseUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 1357US2022193207A1Compositions useful for treatment of pompe diseaseUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 1457US2022193261A1Compositions useful for treatment of pompe diseaseUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 1556US2023210941A1Compositions useful in treatment of krabbe diseaseUNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 1656US2024115733A1Compositions and methods for treatment of niemann pick type a diseaseUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 1756US2023304034A1Compositions for drg-specific reduction of transgene expressionUNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 1855US2023173108A1Compositions useful for treatment of pompe diseaseUNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 1954US2022389457A1Compositions for drg-specific reduction of transgene expressionUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 2054US2023365955A1Compositions and methods for treatment of fabry diseaseUNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 2150US2021077553A1Compositions for drg-specific reduction of transgene expressionUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 2248US2021393713A1Compositions and methods useful for targeting the blood-brain barrierUNIV PENNSYLVANIA·Filed 2019·Application pending·0 cites
- 2346US2022118108A1Compositions useful in treatment of krabbe diseaseUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Juliette Hordeaux files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →